Eli Lilly and NVIDIA plan to invest $1 billion in an AI drug discovery lab
50s
2
12:01, 23.01.2026
American pharmaceutical company Eli Lilly and NVIDIA have announced the creation of a joint AI lab. The lab, with $1 billion in investment, will be located in San Francisco and will bring together NVIDIA engineers and Lilly chemists to develop drugs using AI.
Eli Lilly and NVIDIA AI project
The main goal of the companies' new project is a closed-loop experiment where computing labs work in conjunction with practical research labs. AI agents are planned to work 24/7 to generate data and train models. The platform will be called NVIDIA BioNeMo, and computations will be performed on the Vera Rubin architecture.
The infrastructure is based on a Lilly computer that was announced in 2025. This system is considered the most powerful in the pharmaceutical industry at this stage. AI will be used not only in molecule discovery, but also in logistics, clinical trials, and manufacturing.
Combining scientific expertise and data with computing power could fundamentally impact the pharmaceutical industry. The lab is expected to begin operations as early as March of this year.
Was this article helpful to you?
Yes
No
VPS popular offers
-10%
Windows
€ 18.1 /mo
Billed annually
-18.6%
Windows
€ 38 /mo
Billed annually
-10%
€ 28.99 /mo
Billed annually
-5%
Windows
€ 12.1 /mo
Billed annually
-20.4%
Linux
€ 18 /mo
Billed annually
-9.6%
Windows
€ 156 /mo
Billed annually
-10%
Linux
€ 115.5 /mo
Billed annually
-21.5%
Windows
€ 40 /mo
Billed annually
-26.7%
Linux
€ 10 /mo
Billed annually
-10.1%
Linux
€ 6.23 /mo
Billed annually
